These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 34619037)
1. How the Expansion of the U.S. Preventive Services Task Force Lung Cancer Screening Eligibility May Improve Health Equity Among Diverse Sexual and Gender Minority Populations. Tan ASL; Potter J LGBT Health; 2021 Nov; 8(8):503-506. PubMed ID: 34619037 [TBL] [Abstract][Full Text] [Related]
2. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Moyer VA; Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems. Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916 [TBL] [Abstract][Full Text] [Related]
4. Evaluating efficacy of current lung cancer screening guidelines. Nemesure B; Plank A; Reagan L; Albano D; Reiter M; Bilfinger TV J Med Screen; 2017 Dec; 24(4):208-213. PubMed ID: 28201949 [TBL] [Abstract][Full Text] [Related]
5. The United States Preventive Services Task Force recommendations for lung cancer screening. Blackmon SH; Feinglass SR Thorac Surg Clin; 2015 May; 25(2):199-203. PubMed ID: 25901563 [TBL] [Abstract][Full Text] [Related]
6. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening. Smeltzer MP; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Ramos R; Qureshi T; Mukhopadhyay A; Ray MA; Osarogiagbon RU J Thorac Oncol; 2023 Feb; 18(2):158-168. PubMed ID: 36208717 [TBL] [Abstract][Full Text] [Related]
7. Inaccuracies in electronic health records smoking data and a potential approach to address resulting underestimation in determining lung cancer screening eligibility. Kukhareva PV; Caverly TJ; Li H; Katki HA; Cheung LC; Reese TJ; Del Fiol G; Hess R; Wetter DW; Zhang Y; Taft TY; Flynn MC; Kawamoto K J Am Med Inform Assoc; 2022 Apr; 29(5):779-788. PubMed ID: 35167675 [TBL] [Abstract][Full Text] [Related]
8. Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility. Potter AL; Xu NN; Senthil P; Srinivasan D; Lee H; Gazelle GS; Chelala L; Zheng W; Fintelmann FJ; Sequist LV; Donington J; Palmer JR; Yang CJ J Clin Oncol; 2024 Jun; 42(17):2026-2037. PubMed ID: 38537159 [TBL] [Abstract][Full Text] [Related]
9. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria. Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436 [TBL] [Abstract][Full Text] [Related]
10. Contemporary Implications of U.S. Preventive Services Task Force and Risk-Based Guidelines for Lung Cancer Screening Eligibility in the United States. Landy R; Cheung LC; Berg CD; Chaturvedi AK; Robbins HA; Katki HA Ann Intern Med; 2019 Sep; 171(5):384-386. PubMed ID: 31158854 [No Abstract] [Full Text] [Related]
11. LDCT lung cancer screening eligibility and use of CT scans for lung cancer among sexual minorities. Veliz P; Matthews AK; Arslanian-Engoren C; Evans-Polce RJ; Lee JGL; Boyd CJ; Hughes T; McCabe VV; McCabe SE Cancer Epidemiol; 2019 Jun; 60():51-54. PubMed ID: 30909153 [TBL] [Abstract][Full Text] [Related]
13. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities. Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843 [TBL] [Abstract][Full Text] [Related]
14. State of Cancer Care in America: Achieving Cancer Health Equity Among Sexual and Gender Minority Communities. Kamen CS; Dizon DS; Fung C; Pratt-Chapman ML; Agulnik M; Fashoyin-Aje LA; Jeames SE; Merrill JK; Smith KT; Maingi S JCO Oncol Pract; 2023 Nov; 19(11):959-966. PubMed ID: 37793079 [TBL] [Abstract][Full Text] [Related]
15. Lung cancer screening. Tanoue LT; Tanner NT; Gould MK; Silvestri GA Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325 [TBL] [Abstract][Full Text] [Related]
16. Lung cancer screening: latest developments and unanswered questions. van der Aalst CM; Ten Haaf K; de Koning HJ Lancet Respir Med; 2016 Sep; 4(9):749-761. PubMed ID: 27599248 [TBL] [Abstract][Full Text] [Related]
17. Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening. Wu GX; Goldstein L; Kim JY; Raz DJ Clin Lung Cancer; 2016 Sep; 17(5):e131-e139. PubMed ID: 26872765 [TBL] [Abstract][Full Text] [Related]
18. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113 [TBL] [Abstract][Full Text] [Related]
19. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria. Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946 [No Abstract] [Full Text] [Related]
20. Summaries for patients. Screening for lung cancer: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med; 2014 Mar; 160(5):I-40. PubMed ID: 24378963 [No Abstract] [Full Text] [Related] [Next] [New Search]